Daniel T Dransfield

This inventor holds 24 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Biotherapeutics Development. Top assignees: Dyax Corporation, Bracco Suisse Sa, Bracco International Bv. Active years: 2007-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel T Dransfield. Retrieved from https://idiyas.com/inventor/daniel-t-dransfield

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 12)

% Patents Active = 79.2

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 214(Granted Patents)

Location History:

Hason, MA (US) (2017)
Hanson, MA (US) (2007 - 2022)

Company Filing History:

Bracco International Bv

where one patent can have more than one assignee

Years Active: 2007-2022

Loading Chart...

Areas of Expertise:

Glycan-Interacting Compounds

MMP-14 Binding Protein

HGF Receptor

KDR Binding Peptides

Multivalent Constructs

Cancer Treatment

Osteolytic Disorders

Antibody Binding

Metalloproteinase

Therapeutic Applications

Diagnostic Methods

Peptide Therapy

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11253609 - Glycan-interacting compounds and methods of use (2022-02-22),

2. 10314909 - Combination therapy comprising an MMP-14 binding protein (2019-06-11),

3. 9845340 - Peptides that specifically bind HGF receptor (cMet) and uses thereof (2017-12-19),

4. 9629934 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2017-04-25),

5. 9446155 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2016-09-20),

6. 9056138 - Multivalent constructs for therapeutic and diagnostic applications (2015-06-16),

7. 9051377 - Method for treating breast cancer using antibody binding to MMP-14 (2015-06-09),

8. 9000124 - Peptides that specifically bind HGF receptor (cMet) and uses thereof (2015-04-07),

9. 8663603 - Multivalent constructs for therapeutic and diagnostic applications (2014-03-04),

10. 8642010 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2014-02-04),

11. 8632753 - Multivalent constructs for therapeutic and diagnostic applications (2014-01-21),

12. 8501181 - Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins (2013-08-06),

13. 8183008 - Evaluating MMP expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer (2012-05-22),

14. 8147836 - Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins (2012-04-03),

15. 8106168 - Metalloproteinase binding proteins (2012-01-31),

Title: The Innovative Journey of Daniel T. Dransfield

Introduction:

Daniel T. Dransfield, a talented inventor hailing from Hanson, MA (US), has made significant contributions to the field of innovations with his creative mind and dedication.

Latest Patents:

Daniel T. Dransfield holds several patents in various industries, showcasing his versatility and expertise in inventing groundbreaking solutions to real-world problems.

Career Highlights:

Throughout his illustrious career, Daniel T. Dransfield has been at the forefront of cutting-edge inventions, revolutionizing the way we approach challenges and paving the way for a brighter future.

Collaborations:

Daniel T. Dransfield has collaborated with leading experts and organizations in the innovation space, combining his unique vision with the expertise of others to create impactful solutions.

Conclusion:

In conclusion, Daniel T. Dransfield stands as a beacon of innovation, inspiring others to push the boundaries of what is possible and leaving a lasting impact on the world of inventions.

Profile summary based on public USPTO records.